1 October 2023 v2024.4.1 micro_entity_frs_105_v1_1_1 filingSoftwarefalsetruetruetruefalseNo description of principal activitytruexbrli:purexbrli:sharesiso4217:GBP066388292023-10-012023-12-31066388292023-12-31066388292023-09-3006638829core:WithinOneYear2023-12-3106638829core:WithinOneYear2023-09-30066388292022-10-012023-09-3006638829bus:Director12023-10-012023-12-310663882912023-10-012023-12-3106638829countries:EnglandWales2023-10-012023-12-3106638829bus:AuditExemptWithAccountantsReport2023-10-012023-12-3106638829bus:PrivateLimitedCompanyLtd2023-10-012023-12-3106638829bus:Micro-entities2023-10-012023-12-3106638829bus:FullAccounts2023-10-012023-12-31
Company registration number:
06638829
Framlingham Medical Services Limited
Unaudited Filleted Financial Statements for the period ended
31 December 2023
Framlingham Medical Services Limited
Statement of Financial Position
31 December 2023
31 Dec 202330 Sep 2023
££
Fixed assets -  
457
 
   
Current assets
22,348
 
29,987
 
Creditors: amounts falling due within one year
(14,608
)
(15,634
)
Net current assets
7,740
 
14,353
 
Total assets less current liabilities
7,740
 
14,810
 
Accruals and deferred income
(2,100
)
(1,680
)
Net assets
5,640
 
13,130
 
   
Capital and reserves
5,640
 
13,130
 

Notes to the Financial Statements

1 General information

2 Average number of employees

The average number of persons employed by the company during the period was
2
(2023:
2.00
).
For the period ending
31 December 2023
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
9 February 2024
, and are signed on behalf of the board by:
R Moffatt
Director
Company registration number:
06638829